In the last trading session, 1.28 million shares of the Amarin Corp ADR (NASDAQ:AMRN) were traded, and its beta was 1.36. Most recently the company’s share price was $0.51, and it changed around $0.0 or 0.02% from the last close, which brings the market valuation of the company to $209.78M. AMRN currently trades at a discount to its 52-week high of $1.11, offering almost -117.65% off that amount. The share price’s 52-week low was $0.43, which indicates that the current value has risen by an impressive 15.69% since then.
Amarin Corp ADR stock received a consensus recommendation rating of Underweight, based on a mean score of 4.33. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended AMRN as a Hold, whereas 0 deemed it a Buy, and 2 rated it as Underweight. Amarin Corp ADR is expected to report earnings per share of -0.03 for the current quarter.
Amarin Corp ADR (NASDAQ:AMRN) trade information
Instantly AMRN has showed a green trend with a performance of 0.02% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.5942 on recent trading dayincreased the stock’s daily price by 14.17%. The company’s shares are currently up 5.18% year-to-date, but still down -11.78% over the last five days. On the other hand, Amarin Corp ADR (NASDAQ:AMRN) is -11.50% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $2, which translates to bulls needing to increase their stock price by 74.5% from its current value. Analyst projections state that AMRN is forecast to be at a low of $1.5 and a high of $3.
Amarin Corp ADR (AMRN) estimates and forecasts
The year-over-year growth rate is expected to be -34.10%, down from the previous year.
Consensus estimates provided by 2 financial analysts predict the company will bring in an average of 32.37M in revenue for the current quarter. 1 analysts expect Amarin Corp ADR to make 39.27M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 74.71M and 56.52M respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -56.67%. Forecasts for the next quarter put sales growth at -30.52%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 17.93%. Amarin Corp ADR earnings are expected to increase by 6.37% in 2025, but the outlook is positive 1.60% per year for the next five years.
AMRN Dividends
Amarin Corp ADR’s next quarterly earnings report is expected to be released in April.
KYNAM CAPITAL MANAGEMENT, LP, with 2.9587% or 12.16 million shares worth $8.36 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
SPDR Portfolio Developed World ex-US ETF and Delaware Group Equity Fds IV-Delaware Healthcare Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 252.28 shares worth $0.13 million, making up 0.26% of all outstanding shares. On the other hand, Delaware Group Equity Fds IV-Delaware Healthcare Fund held roughly 190.0 shares worth around $96919.0, which represents about 0.19% of the total shares outstanding.
